|
Index | S&P 500 | P/E | 19.62 | EPS (ttm) | 4.18 | Insider Own | 0.14% | Shs Outstand | 453.93M | Perf Week | 7.28% |
Market Cap | 36.87B | Forward P/E | - | EPS next Y | - | Insider Trans | -9.87% | Shs Float | 453.17M | Perf Month | 9.32% |
Income | 1.90B | PEG | - | EPS next Q | - | Inst Own | 24.42% | Short Float / Ratio | 2.32% / 3.17 | Perf Quarter | 41.43% |
Sales | 18.34B | P/S | 2.01 | EPS this Y | -14.70% | Inst Trans | - | Short Interest | 10.51M | Perf Half Y | - |
Book/sh | 20.72 | P/B | 3.96 | EPS next Y | - | ROA | - | Target Price | 90.00 | Perf Year | - |
Cash/sh | 3.21 | P/C | 25.52 | EPS next 5Y | - | ROE | - | 52W Range | 53.00 - 82.29 | Perf YTD | 40.51% |
Dividend | - | P/FCF | 20.45 | EPS past 5Y | - | ROI | 11.10% | 52W High | -0.32% | Beta | - |
Dividend % | - | Quick Ratio | 0.90 | Sales past 5Y | - | Gross Margin | 39.10% | 52W Low | 54.77% | ATR | 1.90 |
Employees | 50000 | Current Ratio | 1.20 | Sales Q/Q | 14.70% | Oper. Margin | 13.80% | RSI (14) | 71.91 | Volatility | 2.10% 2.28% |
Optionable | Yes | Debt/Eq | 0.88 | EPS Q/Q | 9.70% | Profit Margin | 10.40% | Rel Volume | 0.58 | Prev Close | 82.14 |
Shortable | Yes | LT Debt/Eq | 0.88 | Earnings | Jan 30 BMO | Payout | 0.00% | Avg Volume | 3.31M | Price | 82.03 |
Recom | 2.00 | SMA20 | 7.00% | SMA50 | 11.74% | SMA200 | 18.63% | Volume | 1,916,105 | Change | -0.13% |
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is based in Chicago, Illinois. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR |
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite